MedPath

OneShot Renal Denervation Registry

Phase 2
Terminated
Conditions
Sleep Apnea
Heart Failure
Diabetes Mellitus
Hypertension
Interventions
Device: OneShot Ablation System
Registration Number
NCT01844037
Lead Sponsor
Medtronic Endovascular
Brief Summary

This is a multi-center, prospective registry designed to monitor the outcomes of renal denervation with the OneShot Device in a real-world patient population.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Patient is an acceptable candidate for renal denervation based upon the Instructions for Use.
  • Patient is ≥ 18 years old.
  • Patient provided written informed consent.
Exclusion Criteria
  • Patients who are pregnant, nursing, or planning to become pregnant.
  • Patients who have only one functioning kidney.
  • Allergy to contrast or known hypersensitivity to device materials
  • Patients with renal arteries < 4 mm in diameter.
  • Patients whose life expectancy is less than the planned period of study involvement.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Renal denervationOneShot Ablation SystemPatients will be treated with the OneShot ablation system
Primary Outcome Measures
NameTimeMethod
Change in office systolic blood pressure (SBP) from baseline to 6 months6 months
Secondary Outcome Measures
NameTimeMethod
Acute procedural safety, defined as freedom from renal artery dissection or perforation requiring intervention.One Week
Change in office diastolic blood pressure (DBP)6 and 12 months post procedure
Change in office SBP6 and 12 months post procedure

Trial Locations

Locations (1)

Hospital San Raffaele

🇮🇹

Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath